top of page

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Marker Therapeutics, Inc. - Common Stock (NQ:MRKR)

1.510 +0.030 (+2.03%)

Streaming Delayed Price Updated: 9:41 AM EST, Feb 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Marker Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Marker Therapeutics Stock Drops After Report About Lymphoma Treatment ↗

August 26, 2025

Marker Therapeutics reports strong safety and efficacy data for MT-601 in lymphoma patients, with durable responses and no serious adverse events.

Via Benzinga

Tuesday's pre-market session: top gainers and losers ↗

August 26, 2025

Discover the top movers in Tuesday's pre-market session and stay informed about market dynamics.

Via Chartmill

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

July 17, 2025

Via Benzinga

Here are the top movers in Thursday's session. ↗

July 17, 2025

Keep an eye on the top gainers and losers in Thursday's session, as they reflect the most notable price movements.

Via Chartmill

Gapping stocks in Thursday's session ↗

July 17, 2025

Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Thursday. Let's explore the market movements and identify the stocks with significant gaps.

Via Chartmill

Dow Jumps Over 100 Points; PepsiCo Posts Upbeat Earnings ↗

July 17, 2025

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

July 17, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

March 14, 2025

Via Benzinga

Which stocks have an unusual volume on Monday? ↗

March 10, 2025

Which stocks have an unusual volume on Monday?

Via Chartmill

This Krystal Biotech Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday ↗

March 05, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

December 19, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

December 05, 2024

Via Benzinga

MRKR Stock Earnings: Marker Therapeutics Beats EPS for Q2 2024 ↗

August 14, 2024

MRKR stock results show that Marker Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

MRKR Stock Earnings: Marker Therapeutics Reported Results for Q4 2023 ↗

June 28, 2024

Marker Therapeutics just reported results for the fourth quarter of 2023.

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

June 05, 2024

Via Benzinga

MRKR Stock Earnings: Marker Therapeutics Reported Results for Q1 2024 ↗

May 15, 2024

Marker Therapeutics just reported results for the first quarter of 2024.

Via InvestorPlace

Cancer Cell Therapy Focused Marker Therapeutics Announces Pipeline Prioritization ↗

January 08, 2024

Marker Therapeutics Inc (NASDAQ: MRKR) announced it is restructuring its clinical programs and strategic prioritization of its multi-tumor associated antigen (multiTAA)-specific T cell product...

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

December 29, 2023

Via Benzinga

Marker Therapeutics Inc. (NASDAQ: MRKR) Near the Top of Equities by Percentage Gain on 12/11

December 11, 2023

Via Investor Brand Network

12 Health Care Stocks Moving In Monday's Intraday Session ↗

December 11, 2023

Via Benzinga

Why Is Blood Cancer Focused Marker Therapeutics Stock Trading Higher Today? ↗

September 11, 2023

Marker Therapeutics Inc (NASDAQ: MRKR) released the preliminary results of the first participant treated with MT-601, its multi-tumor associated antigen (multiTAA)-specific T cell product targeting 6...

Via Benzinga

Marker Therapeutics Highlights Its Technology During a WBB Research Institute Webinar on CAR-T and Other Cell Therapies

August 17, 2023

Cranford, New Jersey--(Newsfile Corp. - August 17, 2023) - Marker Therapeutics (NASDAQ: MRKR) highlights...

Via Newsfile

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

August 09, 2023

It's time to start Wednesday with an overview of all the biggest pre-market stock movers traders need to know about this morning!

Via InvestorPlace

Why Avantax Shares Are Trading Higher By Over 27%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

September 11, 2023

Gainers Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) jumped 76% to $28.13 after the company's once-daily oral paltusotine achieved the primary and secondary endpoints in the Phase 3 PATHFNDR-1 study...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

July 31, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

July 28, 2023

Via Benzinga

Why Apellis Pharmaceuticals Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Monday's Session ↗

July 31, 2023

Gainers Yellow Corporation (NASDAQ: YELL) shares jumped 106% to $1.46. The trucking company ceased operations on Sunday, according to a Wall Street Journal report.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

July 24, 2023

Via Benzinga

Why Ryanair Holdings Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

July 24, 2023

Gainers Tupperware Brands Corporation (NYSE: TUP) shares jumped 59% to $1.43 on above-average volume amid retail investor interest.

Via Benzinga

Marker Therapeutics Inc. (NASDAQ: MRKR) Near the Top of Equities by Percentage Gain on 7/24

July 24, 2023

Via Investor Brand Network

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

220 S. Main St.
Colville, WA 99114

Hours: Mon.-Fri., 8 a.m.-5 p.m.

509-684-4567
editor@statesmanexaminer.com

Site by Amber S. King – Creative Design

Home
About
Contact
Submissions

bottom of page